|

Dual Antiplatelet (DAPT) Therapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • J.P.S Henriques1

Indications

  • Percutaneous Coronary Intervention (PCI)1
  • Coronary Arterial Disease (CAD)1
  • Heart Disease1

Other1 trial

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.